Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? (2020)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-0930-7
PubMed Identifier: 32546835
Publication URI: http://europepmc.org/abstract/MED/32546835
Type: Journal Article/Review
Volume: 123
Parent Publication: British journal of cancer
Issue: 5
ISSN: 0007-0920